Bacil Pharma Ltd.
| BSE: 524516 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE711D01018 |
| BSE 00:00 | 27 May | 5.35 |
0.25 (4.90%) |
OPEN
5.20 |
HIGH
5.35 |
LOW
5.20 |
| NSE 05:30 | 01 Jan | Bacil Pharma Ltd |
| OPEN | 5.20 |
| PREVIOUS CLOSE | 5.10 |
| VOLUME | 865 |
| 52-Week high | 9.55 |
| 52-Week low | 3.67 |
| P/E | |
| Mkt Cap.(Rs cr) | 3 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bacil Pharma Ltd. (BACILPHARMA) - Cash Flow
| Figures in Rs crore | 2021 | 2020 | 2019 |
| Opening Cash & Cash Equivalents | 0.04 | 0.09 | 0.27 |
| Net Cash From Operating Activities | -0.40 | -0.38 | -0.30 |
| Net Cash Used In/from Investing Activities | 0.53 | 0.39 | 0.28 |
| Net Cash Used In/from Financing Activities | -0.07 | -0.06 | -0.16 |
| Net (decrease)/increase In Cash and Cash Equivalents |
0.06 | -0.05 | -0.18 |
| Closing Cash & Cash Equivalents | 0.10 | 0.04 | 0.09 |
Quick Links for Bacil Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
